These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6947306)

  • 41. MHPG excretion during sleep deprivation in endogenous depression.
    Matussek N; Römisch P; Ackenheil M
    Neuropsychobiology; 1977; 3(1):23-9. PubMed ID: 895995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Possible pathophysiological mechanisms in subtypes of unipolar depressive disorders based on differences in urinary MHPG levels [proceedings].
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Cole JO; Rosenbaum AH
    Psychopharmacol Bull; 1981 Jan; 17(1):90-91. PubMed ID: 7232668
    [No Abstract]   [Full Text] [Related]  

  • 43. Determination of 3-methoxy-4-hydroxyphenylglycol in urine and the effect of diet on its excretion.
    Sharpless NS
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):257-73. PubMed ID: 21430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do urinary MHPG and plasma drug levels correlate with response to amitriptyline therapy?
    Gaertner HJ; Kreuter F; Scharek G; Wiatr G; Breyer-Pfaff U
    Psychopharmacology (Berl); 1982; 76(3):236-9. PubMed ID: 6808543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 3-Methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations.
    Sacchetti E; Allaria E; Negri F; Biondi PA; Smeraldi E; Cazzullo CL
    Biol Psychiatry; 1979 Jun; 14(3):473-84. PubMed ID: 476232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influences on cortisol and noradrenergic turnover of healthy controls and depressed patients during L-tryptophan loading.
    Maes M; Vandevelde R; Suy E
    J Affect Disord; 1989; 17(2):173-82. PubMed ID: 2549110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MHPG, amitriptyline and affective disorders. A longitudinal study.
    Sacchetti E; Smeraldi E; Cagnasso M; Biondi PA; Bellodi L
    Int Pharmacopsychiatry; 1976; 11(3):157-62. PubMed ID: 992956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary MHPG sulfate as a marker of central norepinephrine metabolism: a commentary.
    Peyrin L
    J Neural Transm Gen Sect; 1990; 80(1):51-65. PubMed ID: 2407268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
    Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam.
    Mooney JJ; Cole JO; Schatzberg AF; Gerson B; Schildkraut JJ
    Am J Psychiatry; 1985 Mar; 142(3):366-7. PubMed ID: 2857533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated 3,4-dihydroxyphenylethyleneglycol (DHPG) excretion in dexamethasone resistant depressed patients.
    Warsh JJ; Hasey G; Cooke RG; Stancer HC; Persad E; Jorna T; Godse DD
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):661-4. PubMed ID: 4089190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is urinary MHPG a real predictor of drug response in primary depression?
    Cazzulo CL; Sacchetti E; Allaria E; Motta A; Conte G; Gasperini M; Smeraldi E
    Adv Biochem Psychopharmacol; 1982; 32():237-47. PubMed ID: 7090894
    [No Abstract]   [Full Text] [Related]  

  • 53. Electroencephalographic sleep profiles in recurrent depression. A longitudinal investigation.
    Kupfer DJ; Frank E; Grochocinski VJ; Gregor M; McEachran AB
    Arch Gen Psychiatry; 1988 Jul; 45(7):678-81. PubMed ID: 3382324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Urinary MHPG in patients with endogenous depression and the effectiveness of antidepressive drugs].
    Puzyński S; Bidziński A; Rode A; Mrozek S; Załuska M
    Psychiatr Pol; 1984; 18(2):115-22. PubMed ID: 6514870
    [No Abstract]   [Full Text] [Related]  

  • 55. EEG sleep, depression, and aging.
    Kupfer DJ; Reynolds CF; Ulrich RF; Shaw DH; Coble PA
    Neurobiol Aging; 1982; 3(4):351-60. PubMed ID: 7170051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low urinary MHPG preceding relapse in a unipolar depressed woman: a case report.
    Nasr SJ; Javaid J; Altman E; Lahmeyer H
    Am J Psychiatry; 1983 Apr; 140(4):486-8. PubMed ID: 6837792
    [No Abstract]   [Full Text] [Related]  

  • 57. Response to maprotiline treatment in depressive patients relationship to urinary MHPG excretion and plasma drug level.
    Gaertner HJ; Golfinopoulos G; Breyer-Pfaff U
    Pharmacopsychiatria; 1982 Sep; 15(5):170-4. PubMed ID: 7178231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of ventral noradrenergic bundle transection and locus coeruleus lesions on urinary 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) excretion in the rat.
    Weise VK; Palkovits M; Kopin IJ
    Brain Res; 1985 Dec; 359(1-2):239-45. PubMed ID: 4075147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary levels of 3-methoxy-4-hydroxyphenylglycol predict symptom severity in selected patients with unipolar depression.
    Garvey MJ; Tuason VB
    Psychiatry Res; 1996 May; 62(2):171-7. PubMed ID: 8771614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol.
    Joseph MH; Baker HF; Johnstone EC; Crow TJ
    Psychopharmacology (Berl); 1979 Jun; 64(1):35-40. PubMed ID: 113829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.